| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 31.76B | 21.69B | 29.68B | 24.44B | 14.07B | 27.68B |
| Gross Profit | 17.69B | 10.57B | 17.68B | 12.99B | 1.07B | 20.91B |
| EBITDA | 12.59B | 8.28B | 13.35B | 8.36B | 61.58B | 18.75B |
| Net Income | 10.54B | 6.58B | 9.58B | 7.49B | 40.57B | 15.08B |
Balance Sheet | ||||||
| Total Assets | 162.28B | 157.86B | 169.97B | 165.54B | 159.85B | 233.02B |
| Cash, Cash Equivalents and Short-Term Investments | 68.66B | 61.18B | 163.87B | 67.61B | 69.48B | 52.60B |
| Total Debt | 15.18B | 15.15B | 15.18B | 15.12B | 149.00M | 183.00M |
| Total Liabilities | 25.24B | 23.74B | 28.84B | 27.90B | 29.10B | 35.63B |
| Stockholders Equity | 137.04B | 134.11B | 141.13B | 137.64B | 130.75B | 197.39B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.04B | 10.42B | -9.88B | -7.28B | -13.03B |
| Operating Cash Flow | 0.00 | 2.04B | 10.44B | -9.57B | -7.25B | -12.96B |
| Investing Cash Flow | 134.00M | 7.40B | 134.00M | -100.00M | 69.64B | 748.00M |
| Financing Cash Flow | -5.45B | -11.61B | -5.45B | 6.84B | -46.23B | -43.47B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥60.80B | 10.05 | 17.21% | 4.27% | 11.13% | 20.95% | |
72 Outperform | ¥2.09T | 3.01 | 20.02% | 2.63% | 31.37% | 148.24% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | ¥113.56B | 18.28 | 5.11% | 5.07% | -26.93% | -29.39% | |
65 Neutral | ¥22.98B | 43.28 | ― | 18.63% | 17.65% | ― | |
47 Neutral | ¥4.04B | -4.99 | 4.15% | ― | -49.54% | -830.10% | |
44 Neutral | ¥15.88B | -12.65 | ― | ― | -22.02% | 30.03% |